Sign in
4

Changes in Ownership

Bone Biologics Corp Filed Acc 0001209191-15-076841

Options or other derivatives

  • Chief Financial Officer acquired 174,918 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Walsh Deina H Chief Financial Officer 2014-11-04 Grant or award · Employee Stock Option (Right to Buy) +174,918 174,918 D: show line 1 in the form
Loading xslF345X03/doc4.xml…